Home › Funds › Susquehanna Portfolio Strategies, LLC › ABBV

Susquehanna Portfolio Strategies, LLC position in ABBV

ABBVIE INC · Health Care

Susquehanna Portfolio Strategies, LLC reported holding 332,871 shares of ABBV (ABBVIE INC) in its Q3 2026 13F filing — a position valued at US$87.1M, representing 1.66% of its reported portfolio and ranking #4 among its reported holdings. Susquehanna Portfolio Strategies, LLC has disclosed ABBV holdings in 5 of the last 12 reported quarters, going back to Q4 2023.

Latest position (Q3 2026)332.87K sh
Reported value held$87.08M
Portfolio Weight1.66%
First reportedQ4 2023
Last changeHold
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How Susquehanna Portfolio Strategies, LLC's ABBV position evolved

Susquehanna Portfolio Strategies, LLC first disclosed a stake in ABBV in Q4 2023 at 34,814 shares (US$5.4M). The position peaked in Q3 2026 at 332,871 shares, worth US$87.1M. Across 5 filings, Susquehanna Portfolio Strategies, LLC held the position steady without any share-count change. The most recent filing (Q3 2026) shows 332,871 shares valued at US$87.1M.

Quarter by quarter

QuarterSharesValueChange
Q4 2023 34.81K $5.40M New
Q1 2024 34.81K $6.34M Hold
Q4 2025 19.89K $4.54M New
Q2 2026 332.87K $83.76M New
Q3 2026 332.87K $87.08M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABBV and 13F data

ABBV (ABBVIE INC) is a Health Care company. 32 other funds we track also report a position in ABBV — the largest reported positions include Vanguard Group (US$41.31B), BlackRock Inc (US$38.97B), VANGUARD CAPITAL MANAGEMENT LLC (US$30.26B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABBV

All ABBV fund holders →

FAQ

How long has Susquehanna Portfolio Strategies, LLC held ABBV?

Susquehanna Portfolio Strategies, LLC has disclosed ABBV holdings in 5 of the last 12 reported quarters, going back to Q4 2023.

What is Susquehanna Portfolio Strategies, LLC's current position in ABBV?

As of Q3 2026, Susquehanna Portfolio Strategies, LLC holds 332.87K shares of ABBV (ABBVIE INC), valued at $87.08M, representing 1.66% of its reported portfolio and ranking #4.

Has Susquehanna Portfolio Strategies, LLC been buying or selling ABBV?

In the latest 13F filing (Q3 2026), Susquehanna Portfolio Strategies, LLC held unchanged its position in ABBV. The position peaked in Q3 2026 at 332.87K shares.

Which other funds hold ABBV?

Other major institutional holders of ABBV include Vanguard Group, BlackRock Inc, VANGUARD CAPITAL MANAGEMENT LLC, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.